Clinical Trials Logo

Clinical Trial Summary

Ineffective hemostasis or a paradoxical prothrombotic state of Acute-on-chronic liver disease (ACLF) has been well established. Thrombelastography measures the dynamics of thrombin production and provides a global assessment of coagulation incorporating the cumulative effect of the interactions at various levels between plasma components and cellular component of coagulation. Through the previous studies(NCT03281278 and NCT04119973), we found that ACLF patients with high ADP inhibition rate had high 28-day mortality.This study aims to validate that high ADP inhibition rate only occurs in patients with liver failure and is related to the severity of the disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Liver Diseases
  • Thrombelastography, Acute Liver Injury, Acute Decompensation, Platelet

NCT number NCT04675125
Study type Observational
Source Nanfang Hospital of Southern Medical University
Contact
Status Completed
Phase
Start date July 6, 2020
Completion date December 5, 2020